By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferring Pharmaceuticals 

Avenue de Rhodanie 60

Lausanne    CH 1007  Switzerland
Phone: 41-21-614-2772 Fax: 41-21-614-2773



Company News
Ferring Pharmaceuticals Named As National Sponsor Of Arthritis Foundation Fundraising Events 11/10/2015 10:32:14 AM
Ferring Pharmaceuticals Receives Acceptance Of Marketing Authorisation Filing From European Medicines Agency For Personalised Fertility Treatment With REKOVELLE (Follitropin Delta) 10/30/2015 10:30:10 AM
Apricus Biosciences (APRI) And Ferring Pharmaceuticals Sign Exclusive Distribution Agreement To Market Topical Erectile Dysfunction Cream Vitaros In Latin American Countries 10/1/2015 7:37:44 AM
Ferring Pharmaceuticals Acquires Global Rights To MILPROSA (Progesterone Vaginal Ring) 9/28/2015 2:09:03 PM
Intralytix And Ferring Pharmaceuticals Collaborate In Novel Bacteriophage-Based IBD Drug Development Project 7/14/2015 9:32:43 AM
Ferring Pharmaceuticals Moves Forward With Early Stage Development Of Bacteriophage Therapy For Inflammatory Bowel Disease 7/13/2015 8:07:22 AM
NovaMedica And Ferring Pharmaceuticals Bring Innovative Gastroenterological Products From Switzerland To Russia 6/2/2015 10:25:22 AM
Ferring Pharmaceuticals Launches 2015 Heart To Heart Video Contest Supporting Families Who've Overcome Infertility 4/21/2015 2:19:52 PM
Ferring Pharmaceuticals Announces European Approval Of New Room Temperature Stable Formulation Of PABAL (Carbetocin) 4/7/2015 10:34:58 AM
Ferring Pharmaceuticals Receives FDA Approval For Growth Hormone Name Change, Acquires ZOMACTON [Somatropin (rDNA Origin)] For Injection And Needle-Free Device In The U.S. 3/31/2015 6:22:30 AM